Blog
0
It’s Best to ‘Be a Pest’ When Self-Advocating
0

“Be a pest. Do it.” Those words from a friend are written on a piece of paper that I keep rediscovering in my mess of a home office. The advice was intended ...

0
Biomarkers May Help Predict Heart Risk in Childhood Cancer Survivors
0

Two biomarkers may help with early heart damage detection in survivors of childhood cancer. In survivors of childhood cancer, recent research has found that ...

0
FDA Approves Keytruda Plus Chemoradiotherapy for Advanced Cervical Cancer
0

The Food and Drug Administration (FDA) has approved Keytruda (pembrolizumab) plus chemoradiotherapy for the treatment of patients with stage 3-4A cervical ...

0
Opioid Use for Pain Persists After Treatment for Many With Cervical Cancer
0

More than six months after treatment for cervical cancer, 40% of patients were still receiving prescriptions for opioids, research found.Nearly 40% of ...

0
Differentiating Muscle-Invasive, Non-Muscle-Invasive Bladder Cancer
0

The “stage” (spread) of bladder cancer may vary from patient to patient, so it’s important to understand the difference between muscle-invasive and ...

0
Celebrating the Holidays as a Patient, Survivor and Caregiver
0

I entered remission from Stage 3B non-small cell lung cancer as a two-time cancer survivor for over ten years on Jan. 2, 2020.Then another year and one-half ...

0
Best Approaches to Switching Therapies for a Patient With Myelofibrosis
0

Reasons to switch JAK inhibitors include worsening blood counts and insufficient symptom or spleen response at maximum doses, with the goal of avoiding gaps ...

0
Michael Strahan’s Daughter Reveals Cancer Diagnosis, Defense Secretary Hospitalized After Cancer Surgery and More
0

Michael Strahan and his daughters. From left to right, Tanita, Sophia, Michael and Isabella. Credit: JC Olivera / Getty ImagesMichael Strahan, host of “Good ...

0
First Patient Dosed in Phase 2 Cancer Vaccine Trial
0

A novel vaccine is being investigated for the treatment of KRAS-mutant pancreatic cancer.The first patient received treatment on a phase 2 trial ...

0
Dosing JAK Inhibitors in Patients With Myelofibrosis
0

For most JAK inhibitors dosing starts at the maximum safe dose, while ruxolitinib often requires lower initial doses and dose reductions over the first 12 ...

0
A Letter from a Cancer Fighter
0

Dear 2024,In preparing my farewells to 2023, I also prepare to put out the welcome mat for you, my dear 2024. I trust you will be a welcomed addition to my ...

0
Statins May Decrease Breast Cancer Mortality in Certain Patients
0

Researchers found that patients with breast cancer had reduced breast cancer-related mortality after using statins.Patients with breast cancer who used ...

CML Alliance
Logo
Enable registration in settings - general
Compare items
  • Total (0)
Compare
0
Shopping cart